Gavril, O.I.; Adam, C.A.; Stamate, T.C.; Gavril, R.S.; Zota, M.I.; Jigoranu, A.R.; Drugescu, A.; Costache, A.D.; Esanu, I.M.; Arhire, L.I.;
et al. Fetuin-A as a Link Between Dyslipidemia and Cardiovascular Risk in Type 2 Diabetes: A Metabolic Insight for Clinical Practice. Biomedicines 2025, 13, 2098.
https://doi.org/10.3390/biomedicines13092098
AMA Style
Gavril OI, Adam CA, Stamate TC, Gavril RS, Zota MI, Jigoranu AR, Drugescu A, Costache AD, Esanu IM, Arhire LI,
et al. Fetuin-A as a Link Between Dyslipidemia and Cardiovascular Risk in Type 2 Diabetes: A Metabolic Insight for Clinical Practice. Biomedicines. 2025; 13(9):2098.
https://doi.org/10.3390/biomedicines13092098
Chicago/Turabian Style
Gavril, Oana Irina, Cristina Andreea Adam, Theodor Constantin Stamate, Radu Sebastian Gavril, Madalina Ioana Zota, Alexandru Raul Jigoranu, Andrei Drugescu, Alexandru Dan Costache, Irina Mihaela Esanu, Lidia Iuliana Arhire,
and et al. 2025. "Fetuin-A as a Link Between Dyslipidemia and Cardiovascular Risk in Type 2 Diabetes: A Metabolic Insight for Clinical Practice" Biomedicines 13, no. 9: 2098.
https://doi.org/10.3390/biomedicines13092098
APA Style
Gavril, O. I., Adam, C. A., Stamate, T. C., Gavril, R. S., Zota, M. I., Jigoranu, A. R., Drugescu, A., Costache, A. D., Esanu, I. M., Arhire, L. I., Graur, M., & Mitu, F.
(2025). Fetuin-A as a Link Between Dyslipidemia and Cardiovascular Risk in Type 2 Diabetes: A Metabolic Insight for Clinical Practice. Biomedicines, 13(9), 2098.
https://doi.org/10.3390/biomedicines13092098
